CABIT: a novel biomarkers-integrated inflammatory risk tool for ischemic heart disease developed in the USA and prospectively validated in China
CABIT:一种新型的、整合生物标志物的缺血性心脏病炎症风险评估工具,由美国开发,并在中国进行了前瞻性验证。
期刊:Journal of Translational Medicine
影响因子:7.5
doi:10.1186/s12967-026-07712-2
Hu, Wenhui; Feng, Han; Xu, Xiaoshuang; Sun, Zhonghua; Lu, Chen; Liu, Ying; Zhou, Ping; Tao, Xinyu; Yang, Jiahui; Cao, Hailong; Wu, Jun; Qu, Chen; Liu, Zhengxia